Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study.

Or AssoulineEli Ben-ChetritYigal HelvizRamzi KurdMarc LeoneSharon Einav

Published in: Advances in therapy (2021)

Patients that were hospitalized in worse condition were more likely to receive more experimental/compassionate drugs. Treatment was unrelated to survival but may have been related to LOS. This finding raises questions regarding the results of studies on medication effects that adjusted for multiple drug administration.

Keyphrases

end stage renal disease
drug administration
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
emergency department
patient reported outcomes
patient reported
adverse drug
electronic health record